Trial to test new approach to improve large tumor treatment
Physician researcher first at UC to receive American Cancer Society career development grant
A new clinical trial at the University of Cincinnati Cancer Center will test the safety and effectiveness of a more targeted radiation dose for patients with large tumors.
Andrew Frankart, MD, is leading the trial, supported by a five-year, $729,000 American Cancer Society (ACS)/American Society for Radiation Oncology (ASTRO) Clinician Scientist Development Grant.
Trial details
The research focuses on a method of delivering radiation called lattice therapy, where certain parts of tumors are preferentially targeted with higher doses of radiation compared to other areas.
“That allows you to achieve higher doses within a tumor, hopefully get better tumor control and also avoid some of the side effects that come with escalated doses of radiation to normal tissue,” said Frankart, a Cancer Center physician researcher and assistant professor of radiation oncology in UC’s College of Medicine.
Frankart recently presented research at the ASTRO annual meeting that found complex lattice therapy plans can be developed quickly enough to be used clinically to treat tumors at various challenging sites in the body.
“We were able to demonstrate successfully that it is not something that takes a lot of extra time despite it being a much more complex planning approach,” he said. “We’ve gotten the information that we need, so we will be focusing more on the clinical outcomes now.”
The grant will support the translation of Frankart’s findings into clinical practice through the trial, which is expected to enroll 37 adult patients and analyze the underlying biology of tumor and immune responses to lattice therapy radiation.
“We’re focusing on patients who have large or bulky tumors. The approach is more based upon where it’s located and how large it is, and those are things that have previously prevented radiation from being as effective,” Frankart said. “Using this new approach to overcome some of those barriers hopefully means it can benefit more patients because we’re broadly including multiple disease sites.”
Frankart has a clinical focus on pediatric cancer, seeing patients at the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center. He said he hopes the findings from this trial for adult patients will also later translate to pediatric cancer.
Career development
Vinita Takiar, MD, PhD, Frankart’s mentor on the project, said the goal is for this research to lay the foundation for a career trajectory for Frankart focused on the use and study of lattice therapy more broadly.
“We look forward to learning how to use it best and which patients will benefit from it the most,” said Takiar, a Cancer Center physician researcher, professor and vice chair of research in UC’s Department of Radiation Oncology. “We also hope to optimize the delivery so that it can be used more broadly in the community.”
Frankart completed his undergraduate degree, medical school and residency all at UC, becoming a faculty member in August. The ACS/ASTRO grant is awarded to an early-career physician interested in having research be a significant part of their practice.
“The grant is certainly a reflection of the excellent mentorship I’ve received through residency and the support of the department more broadly,” he said. “Since my time as an undergrad, I’ve always felt like UC is a special place to be part of within the medical community. Throughout the Cancer Center, at UC and Cincinnati Children’s, you can tell that everyone cares about what they’re doing and they care about the patients as individuals. They also care about each other within the medical team, and I think that leads to outstanding care for our patients.”
Frankart is the first UC researcher to receive the grant, and only one researcher nationwide is awarded this grant every year. Mentor Takiar said Frankart embodies many characteristics essential to being a successful physician researcher, including “attention to detail, learning from every opportunity and putting in the hard work.”
“Career development awards are essential in allowing sufficient research time for early-career investigators to really focus on the research project,” Takiar said. “Dedicated time for both career and project development sets the foundation for physician-scientists for the early years as well as those to come.”
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Featured photo at top of Frankart in a radiation treatment room. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
Bono, Chris Tucker Visit UC To Discuss Africa
December 5, 2002
U2's Bono and comedian-actor Chris Tucker led a delegation from the DATA organization who came to UC to talk about potentially catastrophic problems in Africa.
New Year's Help for Those Looking to Kick the Habit
December 20, 2002
Quitting smoking consistently ranks among the top three resolutions made by New Year's resolvers each year.
E-BRIEF: Let's Toast to a Healthier 2003
January 8, 2003
The New Year often means a new health kick: Vows to tone up and trim down, and maybe going to the doctor and getting ourselves as regularly "maintenanced" as we do our cars. So, this week's University of Cincinnati e-briefing examines the health concerns of the young and old, and what you should be doing to preserve your good health.
Today's ML King Events: One On, One Off
January 8, 2003
A memorial march, presentations, poetry and dance will pay tribute to the slain civil rights leader.
UC Named Lead Organization for OSHA Training Consortium
January 13, 2003
UC Continuing Medical Education (CME) has been selected as the lead organization for the Occupational Safety and Health Administration (OSHA) Great Lakes Training Consortium by the U.S. Department of Labor.
Ignorance of Stroke s Warning Signs a Barrier to Treatment; More Education Needed, UC Researchers Report in JAMA
January 13, 2003
Demographic groups facing the greatest risk of death and disability from stroke are the least likely to recognize stroke s warning signs and risk factors, according to a study by UC researchers published in the January 15 issue of the Journal of the American Medical Association (JAMA).
Ignorance of Stroke s Warning Signs a Barrier to Treatment; More Education Needed, UC Researchers Report in JAMA
January 14, 2003
Demographic groups facing the greatest risk of death and disability from stroke are the least likely to recognize stroke s warning signs and risk factors, according to a study by UC researchers published in the January 15 issue of the Journal of the American Medical Association (JAMA).
UC Researchers Find New Link Between the Eye and the Clock in the Brain
January 20, 2003
Results of a study done by a team of researchers working in the laboratories of Michael Lehman, PhD, professor, Department of Cell Biology, Neurobiology, and Anatomy at the UC College of Medicine, will appear in the February issue of Nature Neuroscience.
UC Researchers Find New Link Between the Eye and the Clock in the Brain
January 21, 2003
Results of a study done by a team of researchers working in the laboratories of Michael Lehman, PhD, professor, Department of Cell Biology, Neurobiology, and Anatomy at the UC College of Medicine, will appear in the February issue of Nature Neuroscience.
Leader of Fetal Surgery to Deliver Lectures at UC
January 31, 2003
An internationally recognized authority on fetal surgery will lecture at the UC Medical Center, representing the first of a series of lectures on fetal surgery presented by the department of Obstetrics and Gynecology (Ob/Gyn).